The global regenerative
medicine market is anticipated to gain the market worth of US$ 178.62
billion by 2026, expanding at a CAGR of 31.5% during the forecast period
2020-2026. The major reasons that escalate the adoption of regenerative
medicine are the growing prevalence of genetic
disorders and chronic diseases and technological advancements in the
regenerative medicine field. Increasing acceptance of regenerative
medicine for organ transplants paired with increasing pipeline activity is
considered as one of the major opportunity areas for market players. The
emergence of stem cell technology, untapped potential of nanotechnology,
increasing prevalence of chronic diseases & trauma emergencies, advancement
in monitoring devices and surgical technologies, rise in incidence of
degenerative diseases, and shortage of organs for transplantation and increase
in focus on stem cells and growth in R&D activities in emerging economies
are expected to supplement the market growth. The high cost associated with
regenerative medicine and ethical issues related to the usage of stem cells and
regenerative medicine acts as the major restraints for the growth of the
overall market. Healthcare expenditure as a proportion of gross domestic
product (GDP) is on the rise. In the US, healthcare spending is expected to grow
by 1.3% points faster than GDP annually, to reach 20.1% of GDP by 2025. This
would lead to the rise in the entry of players and this domain and affect the
regenerative medicine market.
For
Regional/country-level analysis of the overall adoption of Regenerative
Medicine for disease, treatment browse through - https://univdatos.com/report/regenerative-medicine-market-current-analysis-and-forecast-2020-2026
Regenerative
medicine (RM), from tissue engineering (TE) to cell therapy, offers valuable
treatment options, which are rarely considered in daily clinical settings. The
doctors, surgeons, clinicians and, in general, health-care policies are not
prone to substitute conventional approaches with innovative therapies without
extended and thorough experiments. Tissue engineering and/or regenerative
medicine are fields of life science employing both engineering and biological
principles to create new tissues and organs and to promote the regeneration of
damaged or diseased tissues and organs. Major advances and innovations are
being made in the fields of tissue engineering and regenerative medicine and
have a huge impact on three-dimensional bioprinting (3D bioprinting) of tissues
and organs. 3D bioprinting holds great promise for artificial tissue and organ
bioprinting, thereby revolutionizing the field of regenerative medicine. Based
on product type, the global regenerative medicine market is bifurcated into Cell therapy, gene therapy, tissue
engineering and small molecule and biologics. Cell therapy regenerative
medicine dominated the market, with a 60% share in 2019. However, the Gene
Therapy segment is expected to witness the highest CAGR growth of 33.9% during
the forecast period 2020-2026. Based on material type the global Regenerative
Medicine market is segmented
into synthetic materials, biologically derived materials, genetically
engineered materials and others (pharmaceuticals). Biologically
Derived Materials dominated the material type segment, generating revenue of
US$ 16.59 billion in 2019. Cardiovascular, Oncology,
Dermatology, Musculoskeletal, Immunology and Inflammation, Ophthalmology,
Neurology, Others are the major application of Regenerative medicine. The
application of regenerative medicine for the treatment of Oncology
disorder generated revenue of US$ 15.50 billion in 2019.
Request
for Sample of the report browse through - https://univdatos.com/request_form/form/317
For better
understanding of the overall adoption rate of regenerative medicine in major
markets, detailed country-level analysis has been conducted for major
regions/countries including North America (US,
Canada, Rest of North America), Europe (UK, Germany, France, Spain, Italy, Rest
of Europe), Asia-Pacific (China, India, Japan, Australia and South Korea, Rest
of Asia-Pacific), and the Rest of the World (Brazil, South Africa and others).
Based on the estimation, North America dominated the global Regenerative
Medicine Market, generating revenue of US$ 12.10 billion in 2019. Surging research activities in the field of regenerative
medicine, the introduction of CAR-T cell therapies, the emergence of advanced
technologies in tissue engineering and stem cell therapy and rising awareness
of personalized medicine have resulted in the establishment of stem cell
banking and tissue engineering. The increasing demand for regenerative
medicine in the treatment of chronic diseases, cancer, and enhancement in
nanotechnologies would drive the market for regenerative medicine in the North
American region.
For
Regional/country-level analysis of the overall development in the Regenerative Medicine,
sector browse through - https://univdatos.com/report/regenerative-medicine-market-current-analysis-and-forecast-2020-2026
Some of the major players profiled in the study includes Athersys, Inc.,
Corline Biomedical AB, Mesoblast, Nuvasive, Inc., Cook Biotech, Integra
LifeSciences Corporation, Organogenesis, Osiris Therapeutics, Inc., Stryker
Corporation, U.S. Stem Cell, Inc., Spark Therapeutics, Pfizer, REGENXBIO,
Abbott Laboratories, Roche, Sarepta Therapeutics, Gilead Sciences. These companies are entering into
partnerships and mergers & acquisitions to increase their market share.
Some of the key players are also expanding their businesses by increasing their
expenditure on R&D. The industry has also witnessed the emergence of
numerous start-ups in the respective field.
Global Regenerative Medicine Market
Segmentation
Market Insights, by Product
Cell Therapy
Gene Therapy
Tissue Engineering
Small Molecule and
Biologics
Market Insights, by Material Type
Synthetic
Materials
Biologically
Derived Materials
Genetically
Engineered Materials
Other
(Pharmaceuticals)
Market Insights, by Application
Cardiovascular
Oncology
Dermatology
Musculoskeletal
Immunology and
Inflammation
Ophthalmology
Neurology
Others
Market Insights, by Region
North America Regenerative Medicine market
United States
Canada
Rest of North
America
Europe Regenerative Medicine market
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific Regenerative Medicine market
China
Japan
India
Australia
South Korea
Rest of APAC
Rest of the World Regenerative Medicine
market
Brazil
South Africa
Rest of World
Top Companies Profile
Athersys, Inc.
Corline Biomedical
AB
Mesoblast
Nuvasive, Inc.
Cook Biotech
Integra
LifeSciences Corporation
Organogenesis
Osiris
Therapeutics, Inc.
Stryker Corporation
U.S. Stem Cell,
Inc.
Spark Therapeutics
Pfizer
REGENXBIO
Abbott Laboratories
Roche
Sarepta
Therapeutics
Gilead Sciences
Feel free to contact us for any queries - https://univdatos.com/request_form/form/317
UMI
understands that you may have your own business need, hence we also provide
fully customized solutions to clients. The Global Regenerative
Medicine Market can be customized to the country level or any other market
segment.
Contact Us
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
No comments:
Post a Comment